Since the payloads are encapsulated in those vehicles, drugs may become internalized into the PCa cells through endocytosis, and the observed therapeutic effects, in principle, could be due to off-target (i.e., PSMA-independent) effects. The gene discussed is FOLH1; the disease is posterior cortical atrophy.